Effects of Dextran-70 and Albumin on Coagulation in Experimental Hemorrhage in the Guinea Pig

    loading  Checking for direct PDF access through Ovid

Abstract

Background:

Dextran-70 is a more potent plasma volume expander than albumin but use has been hampered because of it's antithrombotic properties. However, also albumin has antithrombotic properties and little is known about relative effects of these two colloids on coagulation in-vivo when controlling for differences in efficacy as plasma volume expanders.

Aim:

Compare effects of dextran-70 and albumin on coagulation at a dose resulting in equal plasma volume expansion.

Methods:

Guinea pigs were subjected to a 25 ml/kg hemorrhage during 20 minutes and randomized to resuscitation with either 6% dextran-70 at a dose of 15 ml/kg or 5% albumin at a dose of 25 ml/kg (n = 14 in each group) during 30 minutes starting one hour of shock. Blood samples were collected at completion of resuscitation and at 4 hours. Plasma volume was measured using 125I-albumin and effect on coagulation was evaluated using whole blood thrombelastography (TEG), measurement of plasma fibrinogen and von Willebrand factor (vWF) concentrations and vWF GP1bA activity.

Results:

Plasma volumes after resuscitation were similar in the groups at both time points. Dextran-70 resulted in a transient prolongation of TEG clot amplification time (K) at completion of resuscitation compared to albumin. TEG clot initiation (R) and strength (MA) did not differ between the treatments at any of the time points. Albumin reduced vWF concentrations to a larger extent than dextran at both time points whereas no difference in p-vWF GP1bA activity or in plasma fibrinogen and could be detected.

Conclusion:

In equipotent doses with regard to plasma volume expansion, dextran-70 transiently prolongs clot amplification time more than albumin whereas dextran-70 reduces plasma vWF concentrations less than albumin.

Related Topics

    loading  Loading Related Articles